The use of drugs in combination for the treatment of cancer: rationale and results.
about
Murine models to evaluate novel and conventional therapeutic strategies for cancerAnnual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.Revisiting perioperative chemotherapy: the critical importance of targeting residual cancer prior to wound healingProblems with immunosuppressive agents in renal diseaseCancer chemotherapy: new strategies for success.Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.Impact of new drugs and biologics on colorectal cancer treatment and costs.Mitochondrial peroxiredoxin III is a potential target for cancer therapyNon-Hodgkin's lymphoma in Manitoba, 1968-77: the impact of chemotherapyEvaluation of single-agent therapy in human colorectal tumour xenografts.Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesSmall cell carcinoma: combined approach to treatmentCross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line.Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapyPreclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform.Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).Imidazoline derivatives: a patent review (2006--present).Understanding resistance to combination chemotherapy.Translational research in neuroendocrine tumors: pitfalls and opportunities.Advances in rational combination chemotherapy.Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study.Tackling the problems of tumour chemotherapy by optimal drug scheduling.Schedule-dependent combined sensitivity testing of anti-cancer agents in human gastric carcinoma cell lines.Cisplatin and doxorubicin toxicosis in dogs with osteosarcoma.The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity.Combination therapy for myelomatosis.Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
P2860
Q24673595-CEEB2B4D-9FF7-45A4-8B65-D6E9C8E1F142Q30847275-2ED8BDBF-C932-4F49-A2D0-30165CA20F5FQ33433283-A458E436-E298-4BE0-BC1B-3D20C99DADE2Q34302895-7632E346-6AF2-420F-AFF3-0D605F1894CCQ34545133-3C60D278-C900-4373-951D-028E45810544Q34886445-3ED24941-DFA3-4A77-87CE-0F6B8097FC71Q34974196-E8AD04F6-6542-4658-A88D-02E47FAC5CF5Q35536098-26A9D956-FE38-45CA-BBE2-FC5456AF780AQ35777355-EB05C69A-34FB-420B-920E-6C8321F12799Q36042129-3A8C1CE7-48B5-48E3-BA1B-8CD315CFF820Q36386428-737A76D5-B7DA-4CEC-A8BA-BA346192F875Q36459777-BAAEE3E9-162F-4339-96C7-7D704CF8E104Q36466678-4EC309AE-A899-4CCD-B079-B74804A53D69Q36952188-8B0C2F3C-7128-4EF8-B566-A8A4B514CC39Q37502313-C8350876-0BF9-4905-9E70-D77E9260E878Q37992086-99EE2C74-FDF5-455D-B225-697B3C9F88D3Q38045922-D304D14A-35A5-4AF3-B82C-960D0DAAC866Q38060916-E425D47F-BDCF-4AB1-9F0B-A6A693BA7198Q38958002-D7BF8B9B-7290-42A1-832D-703EC966BEC1Q39754159-EB405D75-98D3-4899-8887-EAD4AF6CC318Q40597010-A41982B6-6C73-4425-82E4-7156FFAEAE0CQ42087931-3085221B-36F6-47E9-B122-03ED8457EE76Q43686890-5F73215D-2F13-4FA2-A310-97C554026FE4Q44608112-B56B7E8C-E285-4176-841C-3F16D6C9FC54Q47385759-64314ED3-5D1D-4512-B782-3AB638BD5AB4Q53745887-19210DC3-41A5-4244-B494-87A7099A6D39Q58411051-240D26AA-26DD-47D8-9FE6-DB0A1F648946
P2860
The use of drugs in combination for the treatment of cancer: rationale and results.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh
1973年學術文章
@zh-hant
name
The use of drugs in combination for the treatment of cancer: rationale and results.
@en
The use of drugs in combination for the treatment of cancer: rationale and results.
@nl
type
label
The use of drugs in combination for the treatment of cancer: rationale and results.
@en
The use of drugs in combination for the treatment of cancer: rationale and results.
@nl
prefLabel
The use of drugs in combination for the treatment of cancer: rationale and results.
@en
The use of drugs in combination for the treatment of cancer: rationale and results.
@nl
P1476
The use of drugs in combination for the treatment of cancer: rationale and results.
@en
P2093
P304
P356
10.1056/NEJM197305102881905
P407
P577
1973-05-01T00:00:00Z